Edition:
India

Dova Pharmaceuticals Inc (DOVA.OQ)

DOVA.OQ on NASDAQ Stock Exchange Global Market

32.31USD
23 Feb 2018
Change (% chg)

$-0.47 (-1.43%)
Prev Close
$32.78
Open
$33.00
Day's High
$33.36
Day's Low
$31.09
Volume
539,217
Avg. Vol
39,155
52-wk High
$35.52
52-wk Low
$16.98

Latest Key Developments (Source: Significant Developments)

Dova Pharmaceuticals Inc - Supplemental NDA For Avatrombopag in ITP To Be Submitted In Second Half Of 2018
Thursday, 4 Jan 2018 

Jan 3 (Reuters) - Dova Pharmaceuticals Inc ::DOVA PHARMACEUTICALS PROVIDES UPDATE ON DEVELOPMENT STRATEGY FOR AVATROMBOPAG IN IMMUNE THROMBOCYTOPENIC PURPURA (ITP) AND CHEMOTHERAPY-INDUCED THROMBOCYTOPENIA (CIT).DOVA PHARMACEUTICALS INC - SUPPLEMENTAL NDA FOR ITP TO BE SUBMITTED IN SECOND HALF OF 2018.DOVA PHARMACEUTICALS INC - PHASE 3 CLINICAL TRIAL FOR CIT TO BEGIN IN Q2 OF 2018.  Full Article

Dova Pharmaceuticals Announces FDA Acceptance Of The Avatrombopag New Drug Application With Priority Review
Tuesday, 28 Nov 2017 

Nov 27 (Reuters) - Dova Pharmaceuticals Inc ::DOVA PHARMACEUTICALS ANNOUNCES FDA ACCEPTANCE OF THE AVATROMBOPAG NEW DRUG APPLICATION (NDA) WITH PRIORITY REVIEW.DOVA PHARMACEUTICALS INC - PDUFA GOAL DATE FOR AN FDA DECISION IS MAY 21, 2018 FOR NDA​.  Full Article

Dova Pharmaceuticals reports third quarter results
Friday, 10 Nov 2017 

Nov 9 (Reuters) - Dova Pharmaceuticals Inc :Dova Pharmaceuticals reports third quarter 2017 operating and financial results.Dova Pharmaceuticals Inc - qtrly ‍net loss per share, basic and diluted $0.38​.  Full Article